
Liquidity, historical trends, and peer comparisons.
According to CanSino Biologics Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 4.23. This represents a change of 3.14% compared to the average of 4.10 of the last 4 quarters.
The mean historical Current Ratio of CanSino Biologics Inc. over the last ten years is 4.47. The current 4.23 Current Ratio has changed -5.29% with respect to the historical average. Over the past ten years (40 quarters), CASBF's Current Ratio was at its highest in in the September 2020 quarter at 31.06. The Current Ratio was at its lowest in in the March 2018 quarter at 0.
Average
4.47
Median
3.38
Minimum
2.02
Maximum
13.24
Discovering the peaks and valleys of CanSino Biologics Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 208.46%
Maximum Annual Current Ratio = 13.24
Minimum Annual Increase = -75.59%
Minimum Annual Current Ratio = 2.02
| Year | Current Ratio | Change |
|---|---|---|
| 2025 | 3.53 | 47.34% |
| 2024 | 2.40 | 18.79% |
| 2023 | 2.02 | -23.21% |
| 2022 | 2.63 | -18.69% |
| 2021 | 3.23 | -75.59% |
| 2020 | 13.24 | 107.17% |
| 2019 | 6.39 | 208.46% |
| 2018 | 2.07 | -45.20% |
| 2017 | 3.78 | -29.55% |
The current Current Ratio of CanSino Biologics Inc. (CASBF) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
2.65
5-year avg
2.76
10-year avg
4.47
CanSino Biologics Inc.’s Current Ratio is greater than Shenzhen Kangtai Biological Products Co., Ltd. (3.12), less than Hualan Biological Bacterin Inc. (4.63), greater than Chengdu Olymvax Biopharmaceuticals Inc. (1.30), greater than Walvax Biotechnology Co., Ltd. (2.01), less than Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (4.35), greater than Jiangsu gdk Biotechnology Co., Ltd. (1.49), greater than Chongqing Zhifei Biological Products Co., Ltd. (2.92), less than Beijing Tiantan Biological Products Co., Ltd. (8.12), greater than Changchun BCHT Biotechnology Co. (1.21),
| Company | Current Ratio | Market cap |
|---|---|---|
| 3.12 | $14.41B | |
| 4.63 | $9.22B | |
| 1.30 | $12.12B | |
| 2.01 | $18.70B | |
| 4.35 | $32.10B | |
| 1.49 | $1.62B | |
| 2.92 | $35.76B | |
| 8.12 | $25.43B | |
| 1.21 | $6.84B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like CanSino Biologics Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like CanSino Biologics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is CanSino Biologics Inc.'s Current Ratio?
How is the Current Ratio calculated for CanSino Biologics Inc. (CASBF)?
What is the highest Current Ratio for CanSino Biologics Inc. (CASBF)?
What is the 3-year average Current Ratio for CanSino Biologics Inc. (CASBF)?
What is the 5-year average Current Ratio for CanSino Biologics Inc. (CASBF)?
How does the current Current Ratio for CanSino Biologics Inc. (CASBF) compare to its historical average?